Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSamsung El.gdr Regulatory News (SMSN)

Share Price Information for Samsung El.gdr (SMSN)

Share Price is delayed by 15 minutes
Get Live Data
5,355.00    240.00 (4.69%)
Bid:
5,350.00
Ask:
5,355.00
Spread: 5.00 (0.093%)
Market Cap: $1.41t
SMSN Live PriceLast checked at - London Stock Exchange

Intraday Samsung El.gdr Share Chart

  • This share is an international stock.

Approval of Share Repurchase and Cancellation Plan

27 Apr 2017 07:00

RNS Number : 5081D
Samsung Electronics Co. Ld
27 April 2017
Β 

Β 

Β 

Notice Regarding Approval of Share Repurchase and Cancellation Plan

Β 

Samsung Electronics Co., Ltd. (KS005930, KS005935, SMSN, SMSD) ("SEC") announced today that its Board of Directors has authorized the second phase of the share repurchase program we announced on January 24. All repurchased shares will be cancelled. Details of the second phase of the repurchase program are set forth below:

Β 

Β 

β–‘Β Details of Repurchase (2nd phase)

Type of Shares to be Repurchased

1. Common stock

2. Preferred stock

Estimated Total Number of Shares to be Repurchased

1. Common stock: 900,000 (90,000 Daily purchase limit)

2. Preferred stock: 225,000 (22,500 Daily purchase limit)

Estimated Total Purchase Price for Repurchase of Shares

KRW 2.3 trillion

- Common stock: KRW 1,926,000 million (KRW 2,140,000 per share)

- Preferred stock: KRW 369,225 million (KRW 1,641,000 per share)

* Estimated total purchase price noted above is based on the market closing price of

26 April 2017. The actual total purchase price may differ from the current estimate.

Acquisition Method

Open market purchase through intermediaries

- Samsung Securities Co., Ltd.

- Kyobo Securities Co., Ltd.

- Korea Investment & Securities Co., Ltd.

- Mirae Asset Daewoo Securities Co., Ltd.

- Shinhan Investment Corp.

Purchase Period

From 28 April 2017 to 27 July 2017

Other Information

- All repurchased shares will be cancelled

- Current ownership of treasury shares:

Β 1. Common Shares: 17,981,686 (12.9% of the total issued shares)

Β 2. Preferred Shares: 3,229,693 (15.9% of the total issued shares)

β–‘Β Attendance of Independent Directors at the BoD meeting: 5 (100%)

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
MSCEASLXADAXEEF
Date   Source Headline
29th Jun 202610:05 amRNSFuture Business Management Plan
26th Jun 20268:23 amRNSSustainability Report 2026
25th Jun 20268:58 amRNSResponse to Rumors or Media Reports:Undetermined
1st Jun 20268:51 amRNSCorporate Governance Report FY2025
29th May 20269:45 amRNS2026 1Q Interim Business Report
30th Apr 20269:03 amRNS2025 Business Report
30th Apr 20268:51 amRNSTransaction with Affiliate Company
30th Apr 20267:49 amRNSQuarterly Dividend for First Quarter 2026
30th Apr 20267:47 amRNS2026 1Q Earnings Release
24th Apr 20269:30 amRNSReport on Share Repurchase Results
7th Apr 20268:31 amRNSNotice of 1Q 2026 Earnings Release Schedule
7th Apr 20268:31 amRNS1Q 2026 Pre-Earnings Guidance
31st Mar 20268:32 amRNSDecision on Cancellation of Shares
25th Mar 20268:28 amRNSReport on Share Disposition Results
19th Mar 20267:46 amRNSSamsung Electronics Corporate Value Enhancement
18th Mar 20268:38 amRNSCharitable Contribution
18th Mar 20268:28 amRNSDecision on Share Disposition
18th Mar 20268:28 amRNSDecision on Share Repurchase
18th Mar 20268:28 amRNSResults of the 57th Annual General Meeting
12th Mar 20267:55 amRNSAdditional information about Ref. Material(AGM)
12th Mar 20267:55 amRNSAdditional information about Ref. Material(AGM)
12th Mar 20267:47 amRNSReport on Share Repurchase Results
12th Mar 20267:47 amRNSReport on Share Repurchase Results
25th Feb 20267:00 amRNSReplacement of Reference Material for 2026 AGM
13th Feb 20267:44 amRNSCharitable Contributions
13th Feb 20267:43 amRNSReference Material for 2026 AMG
12th Feb 202610:04 amRNS2025 Consolidated Financial Statements
12th Feb 202610:03 amRNS2025 Separate Financial Statements
4th Feb 20268:50 amRNSReport on Share Disposition Results
29th Jan 20268:25 amRNSReport on Share Disposition Results
29th Jan 20268:24 amRNSDecision on Share Disposition
29th Jan 20268:23 amRNSDecision on Share Repurchase
29th Jan 20267:52 amRNS2025 Capex Results
29th Jan 20267:52 amRNSYear-End Dividend for FY2025
29th Jan 20267:00 amRNS2025 4Q Earnings Release
27th Jan 20268:20 amRNSReport on Share Repurchase Results
26th Jan 20267:00 amRNSDecision on Share Disposition
8th Jan 20268:23 amRNSNotice of 4Q 2025 Earnings Release Schedule
8th Jan 20268:23 amRNS4Q 2025 Pre-Earnings Guidance
7th Jan 202610:28 amRNSDecision on Share Repurchase
28th Nov 20258:32 amRNS2025 3Q Interim Business Report
28th Nov 20258:29 amRNSTransaction with Affiliate Company
28th Nov 20258:27 amRNSAppointment of New Chief Executive Officer
28th Nov 20258:27 amRNSCharitable Contribution
5th Nov 20258:19 amRNSReport on Share Disposition Results
30th Oct 20258:16 amRNSDecision on Share Disposition
30th Oct 20257:58 amRNSCharitable Contribution
30th Oct 20257:58 amRNSAnnouncement of Capex Plan for FY 2025
30th Oct 20257:56 amRNSQuarterly Dividend for Third Quarter 2025
30th Oct 20257:00 amRNS2025 3Q Earnings Release

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.